Cita APA

Geva, R., Ramon, J., Perets, R., Pedregal, M., Corral De la Fuente, E., Bardina Santos, J., . . . GARRALDA, E. (2024). Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors.

Citación estilo Chicago

Geva, Ravit, Jorge Ramon, Ruth Perets, Manuel Pedregal, Elena Corral De la Fuente, Jorge Bardina Santos, Maria Vieito , y Elena GARRALDA. Safety and Clinical Activity of JNJ-78306358, a Human Leukocyte Antigen-G (HLA-G) X CD3 Bispecific Antibody, for the Treatment of Advanced Stage Solid Tumors. 2024.

Cita MLA

Geva, Ravit, et al. Safety and Clinical Activity of JNJ-78306358, a Human Leukocyte Antigen-G (HLA-G) X CD3 Bispecific Antibody, for the Treatment of Advanced Stage Solid Tumors. 2024.